EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention

被引:47
作者
de Mulder, Maarten [2 ]
Gitt, Anselm [3 ]
van Domburg, Ron
Hochadel, Matthias [3 ]
Seabra-Gomes, Ricardo [4 ]
Serruys, Patrick W.
Silber, Sigmund [5 ]
Weidinger, Franz [6 ]
Wijns, William [7 ]
Zeymer, Uwe [3 ]
Hamm, Christian [8 ]
Boersma, Eric [1 ]
机构
[1] Erasmus MC, Thoraxcentrum, Dept Cardiol, Clin Epidemiol Unit, NL-3000 CA Rotterdam, Netherlands
[2] Medisch Centrum Alkmaar, Alkmaar, Netherlands
[3] Herzzentrum Ludwigshafen, Ludwigshafen, Germany
[4] Inst Coracao, Lisbon, Portugal
[5] Cardiol Practice & Hosp, Munich, Germany
[6] Krankenhaus Rudolfstiftung, Vienna, Austria
[7] Onze Lieve Vrouw Hosp, Aalst, Belgium
[8] Kerckhoff Klin, Bad Nauheim, Germany
关键词
Percutaneous coronary intervention; Hospital mortality; Peri-procedural complications; Risk stratification; Predictive model; CARDIOVASCULAR DATA REGISTRY; ACUTE MYOCARDIAL-INFARCTION; RISK SCORE; TASK-FORCE; PREDICTION; CARDIOLOGY; ANGIOPLASTY; STRATIFICATION; GUIDELINES; EUROSCORE;
D O I
10.1093/eurheartj/ehr034
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aims The applicability of currently available risk prediction models for patients undergoing percutaneous coronary interventions (PCIs) is limited. We aimed to develop a model for the prediction of in-hospital mortality after PCI that is based on contemporary and representative data from a European perspective. Methods and results Our analyses are based on the Euro Heart Survey of PCIs, which contains information on 46 064 consecutive patients who underwent PCI for different indications in 176 participating European centres during 2005-08. Patients were randomly divided into a training (n = 23 032) and a validation (n = 23 032) set with similar characteristics. In these sets, 339 (1.5%) and 305 (1.3%) patients died during hospitalization, respectively. On the basis of the training set, a logistic model was constructed that related 16 independent patient or lesion characteristics with mortality, including PCI indication, advanced age, haemodynamic instability, multivessel disease, and proximal LAD disease. In both the training and validation data sets, the model had a good performance in terms of discrimination (C-index 0.91 and 0.90, respectively) and calibration (Hosmer-Lemeshow P-value 0.39 and 0.18, respectively). Conclusion In-hospital mortality in PCI patients was well predicted by a risk score that contains 16 factors. The score has strong applicability for European practices.
引用
收藏
页码:1398 / 1408
页数:11
相关论文
共 23 条
[1]
Predicting, mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score) [J].
Addala, S ;
Grines, CL ;
Dixon, SR ;
Stone, GW ;
Boura, JA ;
Ochoa, AB ;
Pellizzon, G ;
O'Neill, WW ;
Kahn, JK .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (05) :629-632
[2]
Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy [J].
de Mulder, Maarten ;
Cornel, Jan-Hein ;
van der Ploeg, Tjeerd ;
Boersma, Eric ;
Umans, Victor A. .
AMERICAN HEART JOURNAL, 2010, 160 (03) :412-419
[3]
Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention [J].
de Winter, RJ ;
Stroobants, A ;
Koch, KT ;
Bax, M ;
Schotborgh, CE ;
Mulder, KJ ;
Sanders, GT ;
van Straalen, JP ;
Fischer, J ;
Tijssen, JGP ;
Piek, JJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (12) :1481-1485
[4]
CORONARY MORPHOLOGICAL AND CLINICAL DETERMINANTS OF PROCEDURAL OUTCOME WITH ANGIOPLASTY FOR MULTIVESSEL CORONARY-DISEASE - IMPLICATIONS FOR PATIENT SELECTION [J].
ELLIS, SG ;
VANDORMAEL, MG ;
COWLEY, MJ ;
DISCIASCIO, G ;
DELIGONUL, U ;
TOPOL, EJ ;
BULLE, TM .
CIRCULATION, 1990, 82 (04) :1193-1202
[5]
The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice [J].
Flynn, MR ;
Barrett, C ;
Cosío, FG ;
Gitt, AK ;
Wallentin, L ;
Kearney, P ;
Lonergan, M ;
Shelley, E ;
Simoons, ML .
EUROPEAN HEART JOURNAL, 2005, 26 (03) :308-313
[6]
Gitt AK, 2009, EUR HEART J, V30, P859
[7]
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction - The CADILLAC risk score [J].
Halkin, A ;
Singh, M ;
Nikolsky, E ;
Grines, CL ;
Tcheng, JE ;
Garcia, E ;
Cox, DA ;
Turco, M ;
Stuckey, TD ;
Na, YG ;
Lansky, AJ ;
Gersh, BJ ;
O'Neill, WW ;
Mehran, R ;
Stone, GW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (09) :1397-1405
[8]
Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials [J].
Iijima, R. ;
Byrne, R. A. ;
Ndrepepa, G. ;
Braun, S. ;
Mehilli, J. ;
Berger, P. B. ;
Schoemig, A. ;
Kastrati, A. .
HEART, 2009, 95 (02) :107-112
[9]
Predicting major adverse cardiac events after percutaneous coronary intervention: The Texas Heart Institute risk score [J].
Madan, Pankaj ;
Elayda, MacArthur A. ;
Lee, Vei-Vei ;
Wilson, James M. .
AMERICAN HEART JOURNAL, 2008, 155 (06) :1068-1074
[10]
Discrimination and calibration of mortality risk prediction models in interventional cardiology [J].
Matheny, ME ;
Ohno-Machado, L ;
Resnic, FS .
JOURNAL OF BIOMEDICAL INFORMATICS, 2005, 38 (05) :367-375